CLX · 10-Q · 2026Q3 · Full report

Liquidity and Debt Position

CLOROX CO /DE/ · 2026-11-02 · Importance 64 · Surprise 42

At September 30, 2026, Clorox had approximately $1,175 million of notes and loans payable, primarily U.S. commercial paper used to fund the GOJO acquisition and a Venture Agreement termination payment. Current liabilities exceeded current assets by $1,023 million, primarily because of those commercial-paper borrowings. The company maintained $1,964 million in revolving credit agreements, with no borrowings under them, and had $10 million outstanding under $39 million of foreign and other credit lines. Clorox stated that it was in compliance with revolving-credit covenants, including a minimum 4.0 interest-coverage ratio.

Key facts

• Clorox stated that termination of its supply chain finance arrangement by the financial institution or a supplier would not be expected to materially affect liquidity or capital resources. source
• Clorox had issued approximately $1,175 million of notes and loans payable as of September 30, 2026, primarily U.S. commercial paper borrowings to finance the previously announced GOJO acquisition and the Venture Agreement termination payment. source
• As of September 30, 2026, Clorox’s current liabilities exceeded current assets by $1,023 million, primarily due to commercial paper borrowings. source
• Clorox expected to have funds to support short- and long-term liquidity and operating needs, based on anticipated positive operating cash flows, access to capital markets supported by its credit ratings and current borrowing availability. source
• As of September 30, 2026, Clorox maintained $1,964 million in revolving credit agreements: a $764 million 364-day facility maturing in March 2027 and a $1,200 million facility maturing in March 2030. source
• Clorox had no borrowings under its revolving credit agreements as of September 30, 2026 or June 30, 2026. source
• Clorox’s revolving credit agreements require a minimum trailing-four-quarter Consolidated EBITDA to interest expense ratio of 4.0. source
• Clorox was in compliance with all revolving-credit covenants as of September 30, 2026 and anticipated continued compliance for the foreseeable future. source